Abstract
Colon cancer is the second leading cause of cancer-related death in men and third leading cause in women. The possibility of developing colorectal cancer in women is 4.4% and in men is 4.7%. According to ACS report, 95 thousand new colon cancer cases and 39 thousand new rectal cancer cases were reported in 2017. Among adult 50 years of age and older, the incidence rate has been reduced by 4.5%, and among those younger than age 50, it is increased by 1.8% from 2008-2012. The improvement in early detection and treatment has declined the mortality rates by 2.8% per year from 2003 to 2012. There is no typical signs and symptoms at the early stages of colorectal cancer. Rectal bleeding, cramping pain in lower abdomen, decreased appetite, and weight loss is the symptoms of colorectal cancer. The survival rate of colorectal cancer is 60-64%.
| Original language | English |
|---|---|
| Pages (from-to) | 5147-5151 |
| Number of pages | 5 |
| Journal | Research Journal of Pharmacy and Technology |
| Volume | 11 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 01-11-2018 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
- Pharmacology (medical)
Cite this
}
The review on genetics, epigenetics, risk factors and diagnosis of colon cancer. / Rajalekshmi, Maheshwari; Shreedhara, Chandrashekhara Shastri; Lobo, Richard; Rao, Polu Picheshwara.
In: Research Journal of Pharmacy and Technology, Vol. 11, No. 11, 01.11.2018, p. 5147-5151.Research output: Contribution to journal › Review article
TY - JOUR
T1 - The review on genetics, epigenetics, risk factors and diagnosis of colon cancer
AU - Rajalekshmi, Maheshwari
AU - Shreedhara, Chandrashekhara Shastri
AU - Lobo, Richard
AU - Rao, Polu Picheshwara
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Colon cancer is the second leading cause of cancer-related death in men and third leading cause in women. The possibility of developing colorectal cancer in women is 4.4% and in men is 4.7%. According to ACS report, 95 thousand new colon cancer cases and 39 thousand new rectal cancer cases were reported in 2017. Among adult 50 years of age and older, the incidence rate has been reduced by 4.5%, and among those younger than age 50, it is increased by 1.8% from 2008-2012. The improvement in early detection and treatment has declined the mortality rates by 2.8% per year from 2003 to 2012. There is no typical signs and symptoms at the early stages of colorectal cancer. Rectal bleeding, cramping pain in lower abdomen, decreased appetite, and weight loss is the symptoms of colorectal cancer. The survival rate of colorectal cancer is 60-64%.
AB - Colon cancer is the second leading cause of cancer-related death in men and third leading cause in women. The possibility of developing colorectal cancer in women is 4.4% and in men is 4.7%. According to ACS report, 95 thousand new colon cancer cases and 39 thousand new rectal cancer cases were reported in 2017. Among adult 50 years of age and older, the incidence rate has been reduced by 4.5%, and among those younger than age 50, it is increased by 1.8% from 2008-2012. The improvement in early detection and treatment has declined the mortality rates by 2.8% per year from 2003 to 2012. There is no typical signs and symptoms at the early stages of colorectal cancer. Rectal bleeding, cramping pain in lower abdomen, decreased appetite, and weight loss is the symptoms of colorectal cancer. The survival rate of colorectal cancer is 60-64%.
UR - http://www.scopus.com/inward/record.url?scp=85063679907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063679907&partnerID=8YFLogxK
U2 - 10.5958/0974-360X.2018.00940.X
DO - 10.5958/0974-360X.2018.00940.X
M3 - Review article
AN - SCOPUS:85063679907
VL - 11
SP - 5147
EP - 5151
JO - Research Journal of Pharmacy and Technology
JF - Research Journal of Pharmacy and Technology
SN - 0974-3618
IS - 11
ER -